While the loss of a transcriptionally active FMR1 promoter due to hypermethylation is a hallmark of FXS, the phenotypic effects of FMR1 silencing are mediated by the loss or aberrant expression of the protein FMRP. This evidence concerns the gene FMR1 and fragile X syndrome.